[go: up one dir, main page]

PL1736160T3 - Oligosacharydy alginianowe i ich pochodne oraz ich wytwarzanie i zastosowanie - Google Patents

Oligosacharydy alginianowe i ich pochodne oraz ich wytwarzanie i zastosowanie

Info

Publication number
PL1736160T3
PL1736160T3 PL05706657T PL05706657T PL1736160T3 PL 1736160 T3 PL1736160 T3 PL 1736160T3 PL 05706657 T PL05706657 T PL 05706657T PL 05706657 T PL05706657 T PL 05706657T PL 1736160 T3 PL1736160 T3 PL 1736160T3
Authority
PL
Poland
Prior art keywords
derivatives
manufacture
well
same
algin oligosaccharides
Prior art date
Application number
PL05706657T
Other languages
English (en)
Inventor
Meiyu Geng
Xianliang Xin
Guangqiang Sun
Original Assignee
Ocean Univ China
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocean Univ China filed Critical Ocean Univ China
Publication of PL1736160T3 publication Critical patent/PL1736160T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04—Disaccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C07H7/033—Uronic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL05706657T 2004-03-24 2005-02-25 Oligosacharydy alginianowe i ich pochodne oraz ich wytwarzanie i zastosowanie PL1736160T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNA2004100238270A CN1562050A (zh) 2004-03-24 2004-03-24 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
PCT/CN2005/000226 WO2005089776A1 (fr) 2004-03-24 2005-02-25 Oligosaccharides d'algine et derives de ceux-ci ainsi que leur fabrication et leur utilisation
EP05706657.3A EP1736160B1 (en) 2004-03-24 2005-02-25 Algin oligosaccharides and the derivatives thereof as well as the manufacture and the use of the same

Publications (1)

Publication Number Publication Date
PL1736160T3 true PL1736160T3 (pl) 2016-01-29

Family

ID=34480338

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05706657T PL1736160T3 (pl) 2004-03-24 2005-02-25 Oligosacharydy alginianowe i ich pochodne oraz ich wytwarzanie i zastosowanie

Country Status (19)

Country Link
US (4) US8835403B2 (pl)
EP (1) EP1736160B1 (pl)
JP (1) JP4709203B2 (pl)
KR (1) KR100844918B1 (pl)
CN (1) CN1562050A (pl)
AU (1) AU2005223923B2 (pl)
BR (1) BRPI0509217B8 (pl)
CA (1) CA2561873C (pl)
DK (1) DK1736160T3 (pl)
EA (1) EA011417B1 (pl)
ES (1) ES2552218T3 (pl)
HU (1) HUE028071T2 (pl)
MA (1) MA28971B1 (pl)
NO (1) NO341226B1 (pl)
PL (1) PL1736160T3 (pl)
PT (1) PT1736160E (pl)
UA (1) UA85226C2 (pl)
WO (1) WO2005089776A1 (pl)
ZA (1) ZA200608813B (pl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562050A (zh) 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
JP4599602B2 (ja) * 2005-04-13 2010-12-15 独立行政法人産業技術総合研究所 糖鎖構造を予測する方法
CN101889027B (zh) * 2007-12-29 2013-05-01 于传兴 低分子量海藻酸及其盐、应用、制法及药物组合物、食品
WO2012138698A1 (en) * 2011-04-08 2012-10-11 Ancora Pharmaceuticals Inc. Synthesis of beta-mannuronic acid oligosaccharides
KR101395181B1 (ko) * 2011-08-02 2014-06-10 부경대학교 산학협력단 알긴산 유래 단량체 또는 중합체를 이용한 알긴산 분석법 및 이를 이용한 바이오매스로부터 추출된 알긴산 분석법
CN102936291B (zh) * 2012-11-15 2014-12-31 深圳大学 一种硒化聚甘露糖醛酸制备方法及其应用
WO2014190935A1 (zh) * 2013-05-30 2014-12-04 苏州科景生物医药科技有限公司 一种多功能组合物及其制备方法与应用
AU2015287703A1 (en) 2014-07-09 2017-02-16 Cadena Bio, Inc. Oligosaccharide compositions and methods for producing thereof
FR3024358B1 (fr) * 2014-08-01 2017-11-10 Soc De Courtage Et De Diffusion Codif Int Compositions cosmetiques et complements alimentaires neuro-protecteurs comprenant de l'oligoalginate ayant un degre de polymerisation de 10 pour lutter contre le vieillissement de la peau.
BR112017015946A2 (pt) * 2015-01-26 2018-07-10 Cadena Bio, Inc. composições de oligossacarídeo para uso como ingredientes alimentares e métodos para produzir as mesmas
WO2016122887A1 (en) 2015-01-26 2016-08-04 Midori Usa, Inc. Oligosaccharide compositions for use animal feed and methods of producing thereof
WO2016159554A1 (ko) * 2015-03-27 2016-10-06 전남대학교 산학협력단 비환원성 말단의 불포화형 만뉴론산 올리고당 및 이를 유효성분으로 포함하는 조성물
EP3964234A1 (en) 2015-04-23 2022-03-09 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
CN106344593B (zh) * 2015-07-17 2020-01-10 上海绿谷制药有限公司 褐藻胶寡糖及其衍生物在制备治疗血管性痴呆药物中的应用
CN106349298B (zh) * 2015-07-17 2021-02-09 上海绿谷制药有限公司 褐藻胶寡糖及其衍生物在改善睡眠障碍中的应用
CN106344592A (zh) * 2015-07-17 2017-01-25 上海绿谷制药有限公司 还原端1位为羧基的甘露糖醛酸寡糖及其衍生物在治疗帕金森氏症中的应用
JP7448174B2 (ja) 2015-11-09 2024-03-12 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア アミロイドベータ中間領域エピトープおよびそれに対する立体配座選択的抗体
EP3374379A4 (en) 2015-11-09 2019-05-15 The University Of British Columbia N-TERMINAL EPITOPES IN AMYLOID BETA AND CONFORMATION-SELECTIVE ANTIBODIES
CN108350053A (zh) 2015-11-09 2018-07-31 英属哥伦比亚大学 淀粉样蛋白β表位及其抗体
WO2017083520A1 (en) * 2015-11-13 2017-05-18 Cadena Bio, Inc. Animal therapeutic and feed compositions and methods of use
CN105395563A (zh) * 2015-12-11 2016-03-16 青岛海洋生物医药研究院股份有限公司 低聚古罗糖醛酸及其衍生物在制备预防和治疗高脂血症及其并发症的药物和保健品中的应用
KR101862459B1 (ko) * 2016-06-21 2018-06-01 전남대학교산학협력단 비환원성 말단의 불포화형 만뉴론산 올리고당(ＯｌｉｇｏＭ)을 유효성분으로 포함하는 운동 능력 개선용 조성물
CA3031135A1 (en) 2016-07-18 2018-01-25 The University Of British Columbia Antibodies to amyloid beta
AU2016420064B2 (en) * 2016-08-15 2021-08-19 Green Valley (Shanghai) Pharmaceuticals Co., Ltd. Method for preparing oligomeric mannuronic diacid
US20180125920A1 (en) 2016-11-09 2018-05-10 The University Of British Columbia Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
MY192462A (en) * 2016-12-30 2022-08-22 Shanghai Inst Materia Medica Cas Composition of mannuronic dicarboxylic acid
ES2984844T3 (es) 2017-07-18 2024-10-31 Univ British Columbia Anticuerpos contra beta amiloide
US12286469B2 (en) 2017-07-18 2025-04-29 The University Of British Columbia Humanized antibodies binding to amyloid-beta (A-beta)
KR101893311B1 (ko) * 2017-11-23 2018-08-29 전남대학교산학협력단 비환원성 말단의 불포화형 만뉴론산 올리고당(ＯｌｉｇｏＭ)을 포함하는 당뇨의 예방 또는 치료용 조성물
CN110652516A (zh) * 2018-06-29 2020-01-07 上海绿谷制药有限公司 甘露糖醛二酸的组合物在治疗帕金森氏症中的应用
CN110652524A (zh) 2018-06-29 2020-01-07 上海绿谷制药有限公司 甘露糖醛二酸的组合物在治疗疼痛中的应用
CN110652517A (zh) 2018-06-29 2020-01-07 上海绿谷制药有限公司 褐藻胶寡糖二酸的组合物
CN110652525A (zh) * 2018-06-29 2020-01-07 上海绿谷制药有限公司 甘露糖醛二酸的组合物在治疗炎症中的应用
CN110652523A (zh) * 2018-06-29 2020-01-07 上海绿谷制药有限公司 甘露糖醛二酸的组合物在治疗血管性痴呆症中的应用
CN110652526A (zh) 2018-06-29 2020-01-07 上海绿谷制药有限公司 甘露糖醛二酸的组合物在治疗糖尿病中的应用
CN109156615B (zh) * 2018-09-18 2021-12-28 青岛农业大学 一种利用褐藻寡糖提高动物精液品质的方法
CN109221811A (zh) * 2018-09-28 2019-01-18 福州大学 一种水产饲料添加剂褐藻寡糖的制备方法
CN109260210A (zh) * 2018-10-11 2019-01-25 深圳大学 寡聚甘露糖醛酸在抑制总Tau表达、磷酸化和聚集中的应用
CN109674813A (zh) * 2018-12-12 2019-04-26 大连海洋大学 用于提高雄性动物生理功能的复合制剂
CN110151773A (zh) * 2019-05-13 2019-08-23 深圳大学 寡聚古罗糖醛酸在预防和治疗Tau蛋白病药物中的应用
WO2020227876A1 (zh) * 2019-05-13 2020-11-19 深圳大学 寡聚古罗糖醛酸在预防和治疗Tau蛋白病药物中的应用
CN112336876A (zh) * 2019-08-06 2021-02-09 上海绿谷制药有限公司 用于识别阿尔茨海默病患者中的糖类药物敏感性患者的方法
CN112336742A (zh) 2019-08-06 2021-02-09 上海绿谷制药有限公司 甘露糖醛酸寡糖治疗Th1主导相关疾病的用途
CN112336861A (zh) * 2019-08-06 2021-02-09 上海绿谷制药有限公司 通过调节氨基酸水平治疗阿尔茨海默病的方法
CN112336860A (zh) * 2019-08-06 2021-02-09 上海绿谷制药有限公司 通过调节肠道微生物治疗阿尔茨海默病的方法
CN110615855B (zh) * 2019-11-01 2020-09-15 农业农村部规划设计研究院 一种生物多糖溶降解制备水溶寡聚衍生物的方法
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
CN110755440B (zh) * 2019-11-20 2023-02-28 中国海洋大学 川芎嗪和甘露糖醛酸的组合物在用于制备治疗血栓性疾病和神经系统疾病的药物中的应用
CN110946804B (zh) * 2020-01-06 2022-07-15 王爱芹 一种预防龋齿和口腔溃疡的漱口水及其制备方法
CN114796243B (zh) * 2021-01-27 2024-04-05 中国海洋大学 一种甘露糖醛酸和益母草碱的药物组合物及其应用
CN115068660A (zh) * 2021-03-11 2022-09-20 吴元通 一种用于创面修复的湿性敷料及其制备方法
CN113730373B (zh) * 2021-07-02 2023-01-24 浙江海洋大学 一种递送姜黄素的zein-AOS复合纳米颗粒及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460945A (en) * 1991-05-30 1995-10-24 Center For Blood Research, Inc. Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response
US5952308A (en) * 1991-07-29 1999-09-14 Pola Chemical Industries Inc. Mineral absorption promoting agent
US5460957A (en) * 1992-04-28 1995-10-24 Maruha Corporation Calcium alginate oligosaccharide and method for producing the same from potassium or sodium alginate
JPH06237783A (ja) * 1993-02-17 1994-08-30 Maruha Corp アルギン酸カリウムオリゴ糖及びその製造法
JP3202365B2 (ja) * 1992-12-04 2001-08-27 株式会社紀文フードケミファ オリゴマンヌロン酸を重合度によって分離する方法
JPH1143439A (ja) * 1997-07-30 1999-02-16 Maruha Corp 血管内皮増殖促進剤
AU2178000A (en) * 1998-12-11 2000-06-26 Salk Institute For Biological Studies, The Co-factors for trophic factors, and methods of use thereof
JP4186294B2 (ja) * 1999-02-26 2008-11-26 セイコーエプソン株式会社 ポリグルロン酸の製造方法
KR100501584B1 (ko) 2000-02-03 2005-07-18 (주)케이비피 저분자 폴리만유로네이트의 제조방법, 혈청지질개선제로서의 이의 신규 용도 및 이를 함유하는 기능성식품 및 건강 보조 식품
ATE303406T1 (de) * 2000-05-12 2005-09-15 Seiko Epson Corp Verfahren zur herstellung von polyuronsäuren
CN1341664A (zh) 2000-09-07 2002-03-27 青岛海洋大学 聚甘露糖醛酸多糖的制备方法及应用
CN1117766C (zh) 2000-09-07 2003-08-13 青岛海洋大学 单一聚合度的甘露糖醛酸的制备方法
JP2002272420A (ja) * 2001-03-19 2002-09-24 Maruha Corp 抗高血圧関連摂取物
CN1161368C (zh) 2001-04-07 2004-08-11 青岛海洋大学 一种褐藻胶寡糖的制造方法
CN1160080C (zh) * 2001-10-01 2004-08-04 青岛海洋大学 褐藻胶寡糖作为制备预防因东莨菪碱所致痴呆药物的应用
CN1401786A (zh) 2001-11-15 2003-03-12 青岛海洋大学 β－D－甘露糖醛酸寡糖单克隆抗体的制备方法
FR2840305B1 (fr) * 2002-05-29 2005-08-19 Ct D Etude Et De Valorisation Procedes d'obtention d'oligo-mannuronates et guluronates, les produits obtenus et leurs utilisations
CN1182146C (zh) * 2002-09-20 2004-12-29 青岛海洋大学 一种利用化学氧化制备褐藻胶寡糖的方法
CN1454992A (zh) 2003-05-16 2003-11-12 中国海洋大学 一种新的褐藻胶裂合酶及其制备方法和应用
CN1486988A (zh) 2003-08-04 2004-04-07 中国海洋大学 还原端1位为羧基的甘露糖醛酸寡糖及其衍生物
CN1473836A (zh) * 2003-08-04 2004-02-11 中国海洋大学 还原端1位为羧基的古罗糖醛酸寡糖及其衍生物
CN1562050A (zh) 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用

Also Published As

Publication number Publication date
EA011417B1 (ru) 2009-02-27
BRPI0509217B1 (pt) 2020-09-24
US9493496B2 (en) 2016-11-15
EA200601756A1 (ru) 2007-04-27
CA2561873A1 (en) 2005-09-29
PT1736160E (pt) 2015-11-20
CA2561873C (en) 2013-01-15
US10213456B2 (en) 2019-02-26
NO341226B1 (no) 2017-09-18
BRPI0509217A (pt) 2007-09-04
US20170112870A1 (en) 2017-04-27
NO20064825L (no) 2006-12-27
BRPI0509217A8 (pt) 2018-03-13
CN1562050A (zh) 2005-01-12
EP1736160A1 (en) 2006-12-27
HUE028071T2 (en) 2016-11-28
MA28971B1 (fr) 2007-11-01
KR100844918B1 (ko) 2008-07-09
US20070254848A1 (en) 2007-11-01
ES2552218T3 (es) 2015-11-26
ZA200608813B (en) 2008-01-08
JP4709203B2 (ja) 2011-06-22
JP2007530718A (ja) 2007-11-01
AU2005223923A1 (en) 2005-09-29
AU2005223923B2 (en) 2008-10-23
US20150105344A1 (en) 2015-04-16
US20190255092A1 (en) 2019-08-22
KR20070007397A (ko) 2007-01-15
WO2005089776A1 (fr) 2005-09-29
EP1736160A4 (en) 2013-01-09
DK1736160T3 (en) 2015-12-07
BRPI0509217B8 (pt) 2022-11-16
EP1736160B1 (en) 2015-08-26
US8835403B2 (en) 2014-09-16
UA85226C2 (ru) 2009-01-12

Similar Documents

Publication Publication Date Title
PL1736160T3 (pl) Oligosacharydy alginianowe i ich pochodne oraz ich wytwarzanie i zastosowanie
IL181235A0 (en) Substituted phenylacetamides and their use as glucokinase activators
EP1951680A4 (en) NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE
EP1828223A4 (en) Novel betulin derivatives, their preparation and their use
IL180682A0 (en) N-hydroxamide derivatives, their preparation and use
IL182126A (en) Preparations containing and used in the history of 5-phenoxyalkoxypsoralen
ZA200606678B (en) 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
IL188520A0 (en) N-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives preparation and use thereof
IL184008A0 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
AU2006321904A8 (en) 1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors
IL177496A0 (en) Amido-substituted hydroxy -6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
EP1951682A4 (en) NEW 2-AMINOPYRIMIDONE OR 2-AMINOPYRIDINONE DERIVATIVES AND THEIR USE
IL178765A0 (en) 2-pyridinylcycloalkylbenzamide derivatives and their use as fungicides
SI1858481T1 (sl) Oftalmološki sestavki in njihova uporaba
EP1951681A4 (en) NEW 2-AMINOPYRIMIDINE DERIVATIVES AND THEIR USE
PL2215908T3 (pl) 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów
PL1786759T3 (pl) Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
EP1912630A4 (en) COMPOSITIONS AND METHODS FOR REDUCING POSTOPERATIVE PAIN
EP1810976B8 (en) Benzonaphthaceneglycoside derivative and use thereof
ZA200704806B (en) Novel betulin derivatives, preparation thereof and use thereof
IL187419A0 (en) Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
EP1824502A4 (en) PREPARATIONS COMPRISING SCLAREOL OR SCLAREOL DERIVATIVES, AND APPLICATIONS
ZA200704650B (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
PL1951687T3 (pl) Pochodne N-hydroksyamidu i ich zastosowanie
HK1120043A (en) Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use